Institut de cancerologie du Gard

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis	Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis	Recruiting	Phase 1 / Phase 2	2026-10-02		NCT04176198
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis	Cytopenia, Hemic and Lymphatic Diseases, Myeloproliferative Disorders, anemia, blood platelet disease, bone marrow disorder, hematologic disorder, primary myelofibrosis, thrombocytopenia	Recruiting	Phase 2	2026-02-05		NCT05037760

Clinical trials